India's Serum Institute to double investment in Biocon Biologics to $300m

India's Serum Institute to double investment in Biocon Biologics to $300m

Biocon Chairperson Kiran Mazumdar-Shaw. Photo: Reuters

Paramita Chatterjee

26 April, 2023

Edited by: Joymitra Rai

Biocon Biologics Serum Institute of India

Printed by Unregistered user on Sat, 06 Dec 2025 22:32:08 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India's Biocon Biologics in fundraising talks with Baring PE Asia

Bicara Therapeutics, a spinout of Kiran Mazumdar-Shaw's Biocon, raises $108m

Read more from India

Meesho raises $28b in India IPO as institutional investors pile in

Zoho, Lingotto pump $45m into Indian electric bike company Ultraviolette